Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2018

01-12-2018 | ASO Author Reflections

ASO Author Reflections: Serum Elastase 1 Level as a Risk Factor for Postoperative Recurrence in Patients with Well-Differentiated Pancreatic Neuroendocrine Neoplasms

Authors: Yoshihide Nanno, MD, PhD, Hirochika Toyama, MD, PhD

Published in: Annals of Surgical Oncology | Special Issue 3/2018

Login to get access

Excerpt

Well-differentiated pancreatic neuroendocrine neoplasms (PanNETs) are heterogeneous in terms of pathology and biology, and their clinical course varies widely.1 Complete resection is the cornerstone of clinical management of patients with PanNETs;2 however, prediction of recurrence after complete resection is still difficult. One of the most widely accepted prognostic factors is the World Health Organization (WHO) histological grading scheme; however, tissue sampling is necessary for this grading, and accurate preoperative assessment of malignancy risk is generally difficult. Preoperative imaging findings have also been used for assessment of malignancy risks;3 however, they are still incomplete to determine aggressive clinical behavior in terms of simplicity or objectivity. Alternative strategies for risk classification in the clinical setting are needed. …
Literature
1.
go back to reference Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9:61–72.CrossRefPubMed Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9:61–72.CrossRefPubMed
2.
go back to reference Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–72.CrossRefPubMed Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–72.CrossRefPubMed
3.
go back to reference Nanno Y, Matsumoto I, Zen Y, et al. Pancreatic duct involvement in well-differentiated neuroendocrine tumors is an independent poor prognostic factor. Ann Surg Oncol. 2017;24:1127–33.CrossRefPubMed Nanno Y, Matsumoto I, Zen Y, et al. Pancreatic duct involvement in well-differentiated neuroendocrine tumors is an independent poor prognostic factor. Ann Surg Oncol. 2017;24:1127–33.CrossRefPubMed
Metadata
Title
ASO Author Reflections: Serum Elastase 1 Level as a Risk Factor for Postoperative Recurrence in Patients with Well-Differentiated Pancreatic Neuroendocrine Neoplasms
Authors
Yoshihide Nanno, MD, PhD
Hirochika Toyama, MD, PhD
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6712-2

Other articles of this Special Issue 3/2018

Annals of Surgical Oncology 3/2018 Go to the issue